Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Louise Platen"'
Autor:
Krischan Braitsch, Samuel D. Jeske, Jacob Stroh, Maike Hefter, Louise Platen, Quirin Bachmann, Lutz Renders, Ulrike Protzer, Katharina S. Götze, Peter Herhaus, Mareike Verbeek, Christoph D. Spinner, Florian Bassermann, Marion Högner, Bernhard Haller, Jochen Schneider, Michael Heider
Publikováno v:
Vaccines, Vol 12, Iss 8, p 871 (2024)
Patients with hematologic malignancies still face a significant risk of severe coronavirus disease 2019 (COVID-19). The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)-neutralizing monoclonal antibody combination tixagevimab/cilgavi
Externí odkaz:
https://doaj.org/article/4b7f987275f945a7ba77c83efab64ece
Autor:
Bo-Hung Liao, Louise Platen, Myriam Grommes, Cho-Chin Cheng, Christopher Holzmann-Littig, Catharina Christa, Bernhard Haller, Verena Kappler, Romina Bester, Maia Lucia Werz, Eva Platen, Peter Eggerer, Laëtitia Tréguer, Claudius Küchle, Christoph Schmaderer, Uwe Heemann, Lutz Renders, Ulrike Protzer, Matthias Christoph Braunisch
Publikováno v:
Vaccines, Vol 12, Iss 3, p 308 (2024)
Background: Hemodialysis patients have reduced serologic immunity after SARS-CoV-2 vaccination compared to the general population and an increased risk of morbidity and mortality when exposed to SARS-CoV-2. Methods: Sixty-six hemodialysis patients im
Externí odkaz:
https://doaj.org/article/94485bd5f28543fe83352e3af06f68fa
Autor:
Nina Körber, Christopher Holzmann-Littig, Gesa Wilkens, Bo-Hung Liao, Maia L. Werz, Louise Platen, Cho-Chin Cheng, Myriam Tellenbach, Verena Kappler, Viktor Lehner, Hrvoje Mijočević, Catharina Christa, Volker Assfalg, Uwe Heemann, Christoph Schmaderer, Ulrike Protzer, Matthias C. Braunisch, Tanja Bauer, Lutz Renders
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundKidney transplant recipients (KTRs) are at high risk for a severe course of coronavirus disease 2019 (COVID-19); thus, effective vaccination is critical. However, the achievement of protective immunogenicity is hampered by immunosuppressive
Externí odkaz:
https://doaj.org/article/02841bec090b408baea70bea20e94957
Autor:
Christopher Holzmann-Littig, David Stadler, Maria Popp, Peter Kranke, Falk Fichtner, Christoph Schmaderer, Lutz Renders, Matthias Christoph Braunisch, Tarek Assali, Louise Platen, Marjo Wijnen-Meijer, Julia Lühnen, Anke Steckelberg, Lisa Pfadenhauer, Bernhard Haller, Cornelia Fuetterer, Christian Seeber, Christian Schaaf, on behalf of the CEOsys Consortium
Publikováno v:
Healthcare, Vol 11, Iss 11, p 1602 (2023)
Background: The COVID-19 pandemic has led to a flood of—often contradictory—evidence. HCWs had to develop strategies to locate information that supported their work. We investigated the information-seeking of different HCW groups in Germany. Meth
Externí odkaz:
https://doaj.org/article/d90a63a2002148889bd4a716816c61f0
Autor:
Cho-Chin Cheng, Louise Platen, Catharina Christa, Myriam Tellenbach, Verena Kappler, Romina Bester, Bo-Hung Liao, Christopher Holzmann-Littig, Maia Werz, Emely Schönhals, Eva Platen, Peter Eggerer, Laëtitia Tréguer, Claudius Küchle, Christoph Schmaderer, Uwe Heemann, Lutz Renders, Ulrike Protzer, Matthias Christoph Braunisch
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1328 (2022)
Hemodialysis patients are exposed to a markedly increased risk when infected with SARS-CoV-2. To date, it is unclear if hemodialysis patients benefit from four vaccinations. A total of 142 hemodialysis patients received four COVID-19 vaccinations unt
Externí odkaz:
https://doaj.org/article/1fdcbc0627d14e36a5986b2ecef6e6a7
Autor:
Fedor Kundert, Louise Platen, Takamasa Iwakura, Zhibo Zhao, Julian A. Marschner, Hans-Joachim Anders
Publikováno v:
Kidney Research and Clinical Practice, Vol 37, Iss 3, Pp 185-196 (2018)
Acute kidney injury is a clinical syndrome that can be caused by numerous diseases including acute tubular necrosis (ATN). ATN evolves in several phases, all of which are accompanied by different immune mechanisms as an integral component of the dise
Externí odkaz:
https://doaj.org/article/c341986bd4854046aff87f7edde0c79b
Autor:
Consortium, Christopher Holzmann-Littig, David Stadler, Maria Popp, Peter Kranke, Falk Fichtner, Christoph Schmaderer, Lutz Renders, Matthias Christoph Braunisch, Tarek Assali, Louise Platen, Marjo Wijnen-Meijer, Julia Lühnen, Anke Steckelberg, Lisa Pfadenhauer, Bernhard Haller, Cornelia Fuetterer, Christian Seeber, Christian Schaaf, on behalf of the CEOsys Consortium on behalf of the CEOsys
Publikováno v:
Healthcare; Volume 11; Issue 11; Pages: 1602
Background: The COVID-19 pandemic has led to a flood of—often contradictory—evidence. HCWs had to develop strategies to locate information that supported their work. We investigated the information-seeking of different HCW groups in Germany. Meth
Autor:
Louise Platen, Bo-Hung Liao, Myriam Tellenbach, Cho-Chin Cheng, Christopher Holzmann-Littig, Catharina Christa, Christopher Dächert, Verena Kappler, Romina Bester, Maia Lucia Werz, Emely Schönhals, Eva Platen, Peter Eggerer, Laëtitia Tréguer, Claudius Küchle, Christoph Schmaderer, Uwe Heemann, Oliver T. Keppler, Lutz Renders, Matthias Christoph Braunisch, Ulrike Protzer
BackgroundIndividuals on hemodialysis are more vulnerable to SARS-CoV-2 infection than the general population due to end-stage kidney disease-induced immunosuppression.Methods26 hemodialysis patients experiencing SARS-CoV-2 infection after 3rdvaccina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::404c1b129e2ac533f383b7687aef6fb4
https://doi.org/10.1101/2023.03.14.23287246
https://doi.org/10.1101/2023.03.14.23287246
Autor:
Cho-Chin Cheng, Louise Platen, Catharina Christa, Myriam Tellenbach, Verena Kappler, Romina Bester, Bo-Hung Liao, Christopher Holzmann-Littig, Maia Werz, Emely Schönhals, Eva Platen, Peter Eggerer, Laëtitia Tréguer, Claudius Küchle, Christoph Schmaderer, Uwe Heemann, Lutz Renders, Ulrike Protzer, Matthias Christoph Braunisch
BackgroundHemodialysis patients are exposed to a markedly increased risk when infected with SARS-CoV-2. To date it is unclear if hemodialysis patients benefit from a fourth vaccination.MethodsA total of 142 hemodialysis patients (median age 72.6 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e914dcb956894f2ccc8065a769c97865
https://doi.org/10.1101/2022.06.22.22276787
https://doi.org/10.1101/2022.06.22.22276787
Autor:
Cho-Chin Cheng, Louise Platen, Catharina Christa, Myriam Tellenbach, Verena Kappler, Romina Bester, Bo-Hung Liao, Christopher Holzmann-Littig, Maia Werz, Emely Schönhals, Eva Platen, Peter Eggerer, Laëtitia Tréguer, Claudius Küchle, Christoph Schmaderer, Uwe Heemann, Lutz Renders, Ulrike Protzer, Matthias Christoph Braunisch
Publikováno v:
Vaccines; Volume 10; Issue 8; Pages: 1328
Vaccines 10:1328 (2022)
Vaccines 10:1328 (2022)
Hemodialysis patients are exposed to a markedly increased risk when infected with SARS-CoV-2. To date, it is unclear if hemodialysis patients benefit from four vaccinations. A total of 142 hemodialysis patients received four COVID-19 vaccinations unt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a73ae10d574d217cdbf5962955af4f1
https://mediatum.ub.tum.de/1689301
https://mediatum.ub.tum.de/1689301